AU2626699A - Self-replicating vector for dna immunization against hiv - Google Patents

Self-replicating vector for dna immunization against hiv

Info

Publication number
AU2626699A
AU2626699A AU26266/99A AU2626699A AU2626699A AU 2626699 A AU2626699 A AU 2626699A AU 26266/99 A AU26266/99 A AU 26266/99A AU 2626699 A AU2626699 A AU 2626699A AU 2626699 A AU2626699 A AU 2626699A
Authority
AU
Australia
Prior art keywords
self
against hiv
immunization against
dna immunization
replicating vector
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU26266/99A
Inventor
Kai Krohn
Part Peterson
Paivi Annamari Ranki
Marja Tahtinen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Finnish Immunotechnology Ltd
Original Assignee
Finnish Immunotechnology Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Finnish Immunotechnology Ltd filed Critical Finnish Immunotechnology Ltd
Publication of AU2626699A publication Critical patent/AU2626699A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16311—Human Immunodeficiency Virus, HIV concerning HIV regulatory proteins
    • C12N2740/16322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2800/00—Nucleic acids vectors
    • C12N2800/10—Plasmid DNA
    • C12N2800/108—Plasmid DNA episomal vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/42—Vector systems having a special element relevant for transcription being an intron or intervening sequence for splicing and/or stability of RNA
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2840/00—Vectors comprising a special translation-regulating system
    • C12N2840/20—Vectors comprising a special translation-regulating system translation of more than one cistron

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Plant Pathology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Microbiology (AREA)
  • AIDS & HIV (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
AU26266/99A 1998-02-27 1999-02-26 Self-replicating vector for dna immunization against hiv Abandoned AU2626699A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FI980463 1998-02-27
FI980463A FI105105B (en) 1998-02-27 1998-02-27 A self-replicating DNA vector for immunization against HIV
PCT/FI1999/000152 WO1999043841A1 (en) 1998-02-27 1999-02-26 Self-replicating vector for dna immunization against hiv

Publications (1)

Publication Number Publication Date
AU2626699A true AU2626699A (en) 1999-09-15

Family

ID=8551073

Family Applications (1)

Application Number Title Priority Date Filing Date
AU26266/99A Abandoned AU2626699A (en) 1998-02-27 1999-02-26 Self-replicating vector for dna immunization against hiv

Country Status (8)

Country Link
EP (1) EP1056879A1 (en)
CN (1) CN1295623A (en)
AP (1) AP2000001892A0 (en)
AU (1) AU2626699A (en)
FI (1) FI105105B (en)
OA (1) OA11528A (en)
RU (1) RU2232815C2 (en)
WO (1) WO1999043841A1 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI107737B (en) * 1999-12-23 2001-09-28 Atso Raasmaja Plasmid for expression of the tyrosine hydroxylase gene in the brain
FI116851B (en) 2001-05-03 2006-03-15 Fit Biotech Oyj Plc Expression vector, its uses and process for its preparation and products containing it
EP1279404A1 (en) * 2001-07-26 2003-01-29 Istituto Superiore di Sanità Use of HIV-1 tat, fragments or derivatives thereof, to target or to activate antigen-presenting cells, to deliver cargo molecules for vaccination or to treat other diseases
JP2006502704A (en) 2002-05-16 2006-01-26 バヴァリアン・ノルディック・アクティーゼルスカブ HIV regulatory / accessory protein fusion protein
KR101471043B1 (en) * 2009-01-08 2014-12-09 주식회사 바이오리더스 Stable Constitutively High Expression Vector for Anti-HPV Vaccine and Lactic Acid Bacteria Transformed by Thereof
LT3216871T (en) * 2011-10-17 2022-03-25 Regeneron Pharmaceuticals, Inc. Restricted immunoglobulin heavy chain mice
AU2017277810A1 (en) * 2016-06-03 2018-12-06 Temple University - Of The Commonwealth System Of Higher Education Negative feedback regulation of HIV-1 by gene editing strategy
CN110747214B (en) * 2019-03-13 2021-12-31 深圳市臻质医疗科技有限公司 DNA fragment, mRNA-antibody fusion molecule with long-acting expression and cell specific binding capacity and preparation method thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2241172C (en) * 1995-12-29 2008-08-19 Estonian Biocentre Episomal vector and uses thereof

Also Published As

Publication number Publication date
FI980463A (en) 1999-09-27
EP1056879A1 (en) 2000-12-06
OA11528A (en) 2004-05-07
CN1295623A (en) 2001-05-16
FI105105B (en) 2000-06-15
AP2000001892A0 (en) 2000-09-30
WO1999043841A1 (en) 1999-09-02
RU2232815C2 (en) 2004-07-20
FI980463A0 (en) 1998-02-27

Similar Documents

Publication Publication Date Title
EP1002559B8 (en) Gun-shaped controller
EP2055450B8 (en) Safety razors
ZA98417B (en) Gas phase polymerization process.
AU2454600A (en) Razors
AU5390998A (en) Process for preparing continuously variable-composition copolymers
AU6512299A (en) Gemini virus vectors for gene expression in plants
AU9623898A (en) Vaccines
AU7598398A (en) Locking pliers
AU6114700A (en) Novel system for the sequential, directional cloning of multiple dna sequences
AU7933898A (en) Dna polymerase-related factors
AU7984198A (en) Process for preparing hydrofluorocarbons
AU1285300A (en) Hiv vaccine
AU1041101A (en) Gas phase polymerization process
AU2001228199A1 (en) Optimum steering system geometry
AU2495300A (en) Lentivirus vector system
AU2002214157A1 (en) Polymerisation process
AU2626699A (en) Self-replicating vector for dna immunization against hiv
AU2001246703A1 (en) Dna immunization vectors
AU5234100A (en) Isobutene polymerisation process
ZA992543B (en) Gluten-free beer.
AU2735897A (en) Ribosomes as vectors for rna
AU3944999A (en) Gas phase polymerisation process
AU6005000A (en) Polymerisation process
HUP0003452A3 (en) Process for the preparation of 1-aryl-3-cyclopropyl-1,3-propanediones
AU8232498A (en) Gripping aid

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase